Awardee Resources Hub

Welcome to the FAILSAFE Grant Awardee Resource Hub! This page has been created to provide you with a dedicated space for accessing key resources and information related to your project and the award you have received through the FAILSAFE Project.

While you will continue to receive important updates and communications via email, this hub will serve as a convenient, central location where you can easily find relevant documents, guidelines, and any other essential information to support your work.

We encourage you to check back regularly for updates, new resources, and tools designed to help you make the most of your FAILSAFE grant. This platform is here to support your project’s success and contribute to our shared mission of reducing the global fungal disease burden.

Feel free to explore, and reach out to our team if you have any questions or need further assistance FAILSAFE@exeter.ac.uk.

This page is currently under construction so more updates to follow!

Document library and resources area

Post Award FAQs and Guidance

R1 Pre and post-award guidance and FAQ V1.1

Workshop Information and Presentations

Thank you for taking the time to attend the FAILSAFE Post Award Workshop on the 25th of November 2025 at 13:00. Below you will find the presentation.

FAILSAFE Workshop 1 Post Award

Reporting Templates and Guidance

Reporting guidance

Reporting Template (blank) – please note your template will be provided to you pre populated with your application information

Reporting budget template (blank) again, please note your template will be provided to you pre populated with your application information

Reporting budget template guidance document and an example of a completed finance reporting budget

 

Partnership support information

One of the primary objectives of the projects funded by FAILSAFE is to advance global research and development (R&D) efforts aimed at reducing the threat of fungal antimicrobial resistance (fAMR) for the benefit of people in low- and middle-income countries (LMICs).

To achieve this, funded projects must have a clear R&D focus, demonstrating innovation and the potential to advance products along the development pipeline. Your application would have outlined specific outcomes and future deliverables, such as securing follow-on funding, protecting intellectual property, and generating publications.

To support you in achieving these goals, we have a dedicated and experienced commercial partner. Angus Urquhart (a.urquhart@exeter.ac.uk), the Impact and Partnership Development Manager for the FAILSAFE Project, brings over 30 years of commercial expertise to assist you in reaching your objectives and ensuring that your project delivers the impact you aim for.

How can we support your project?

• We can work closely with you to understand your project and identify areas with potential for commercial application.
• We can help explore potential partners to develop your project commercially.
• We can collaborate with you to understand the market, how it relates to your project, and develop the right partnerships for success.
• We can provide marketing support, including outreach materials and social media planning.
• We can assist in promoting your advances and discoveries through our extensive and long-established connections with universities, SMEs, and pharmaceutical companies. Additionally, we offer access to key translational infrastructure available at the University of Exeter.

Partnership frequently asked questions (FAQs)

I have a product or solution and want help with finding an industry partner, how can you help?

Yes, we have a dedicated Commercial Lead on the project and there are several things we can offer to help you here. We will be meeting individually with all grant awardees to discuss the commercial application of your project. We can help you with structuring pitch materials, helping you with marketing and social media, connect you with potential industry partners from our wider network and help structure and negotiate contracts.

What support will you be able to offer me with my research?

We can provide marketing and commercial support and help you translate your research into a commercially viable proposition as laid out above.

I already have a potential commercial partner. What happens next?

We can work with you and your potential partner to ensure the best commercial outcome for you. We would ask you to introduce us to your partner and we can understand their objectives and preferred outcomes and ensure your project delivers what they need and a mutually beneficial agreement is reached.

What marketing resources can you offer?

We can help you design pitch decks and overview documents, advise on social media strategy and help you create social media collateral.

Help and support

For further information and assistance with finding partners for your project, please contact Angus Urquhart, our FAILSAFE Impact and Partnership Development Manager, at: a.urquhart@exeter.ac.uk 

 

Publications, articles and media engagement

Please notify us of any publications as well as public engagement activities or media/press coverage related to your project in advance. Any publications, outputs, or downstream funding related to the award must acknowledge the funds provided through FAILSAFE. All written materials must contain an acknowledgement of the role of GAMRIF (through DHSC) and UK aid and, when mentioning research findings or opinions, an appropriate disclaimer.

As per clause 13 in the Terms and Conditions, please take note of the following:

• The Lead Applicant Institution agrees to follow the Global AMR Innovation Fund Communications Guideline (2022), ensuring proper use of logos, acknowledgments, and digital communication as outlined by the Authority via UoE.
• Peer-reviewed research articles must be Open Access with a ‘CC BY’ license to enable free sharing and reuse.
• Official documents about the funded research require prior written approval from UoE or the Authority, except where acknowledgment templates are already provided.
• All materials and presentations about the Grant must credit the Authority and UK aid, using approved names and logos in line with branding guidelines.
• Third-party use of logos requires prior permission from UoE or the Authority.
• The Institution will also support the Authority by accommodating reasonable requests for visits, reports, statistics, photos, or case studies to promote the Grant and its outcomes.

Please use the following boiler plate text as relevant.

For research papers and articles:

 This research is [co] funded by the UK Department of Health and Social Care (DHSC) as part of the Global AMR Innovation Fund (GAMRIF). This is a One Health UK aid fund that supports research and development around the world to reduce the threat of antimicrobial resistance (AMR) in humans, animals and the environment for the benefit of people in low- and middle-income countries (LMICs). The views expressed in this publication are those of the author(s) and not necessarily those of the UK DHSC.

For press releases:

Proposed text for the body of the press release:

This research is [co] funded by the UK Department of Health and Social Care (DHSC) as part of the Global AMR Innovation Fund (GAMRIF). This is a One Health UK aid fund that supports research and development around the world to reduce the threat of antimicrobial resistance (AMR) in humans, animals and the environment for the benefit of people in low- and middle-income countries (LMICs).

Proposed text for editors notes:

The Department of Health and Social Care (DHSC) is the UK Government Department which is responsible for helping people to live more independent, healthier lives for longer. The Global AMR Innovation Fund (GAMRIF) is a One Health UK aid fund that supports research and development around the world to reduce the threat of antimicrobial resistance (AMR) in humans, animals and the environment for the benefit of people in low- and middle-income countries (LMICs). GAMRIF core objectives are to develop innovative One Health solutions to tackle AMR; increase availability of context-specific, accessible, and affordable innovations for LMICs; establish international research partnerships with industry, academia, and governments; and collaborate with and leverage additional funding from other global donors.

 

Please use the full logo available here.